Loading people...
Jennie Daisak is a Vice President at Bain Capital Life Sciences based in Boston, Massachusetts, where she focuses on evaluating and supporting emerging companies across the broader life sciences sector. She joined the alternative investment firm in 2021 after beginning her financial career in the healthcare investment banking division at J.P. Morgan. During her tenure at the multinational bank, she advised various biotechnology and pharmaceutical clients on complex mergers, acquisitions, and corporate financings. Daisak graduated summa cum laude from the University of Pennsylvania through the highly selective Roy and Diana Vagelos Program in Life Sciences and Management. She earned a Bachelor of Arts in biology alongside a Bachelor of Science in economics with a finance concentration from the Wharton School, which supports her current investments in pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools.
Jennie Daisak is a key member of the investment team at Bain Capital Life Sciences, where she holds the position of Associate. In this capacity, Jennie plays a crucial role in the firm's mission to partner with and invest in groundbreaking companies that are transforming the healthcare landscape. Her work involves rigorous analysis and strategic insight into potential investment opportunities within the dynamic life sciences sector.
At Bain Capital Life Sciences, Jennie Daisak contributes to the firm's comprehensive approach to identifying and supporting companies poised for significant growth and impact. The firm is known for its deep expertise in areas such as biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health. Jennie's responsibilities typically include conducting extensive due diligence, performing market research, analyzing financial models, and evaluating scientific and clinical data to assess the viability and potential of prospective investments. She works closely with senior partners and management teams of portfolio companies, providing analytical support and strategic input throughout the investment lifecycle.
While specific details of Jennie Daisak's career background are not publicly detailed, individuals in her role at a prominent life sciences investment firm often possess a strong foundation in science, medicine, or finance. This can include advanced degrees in relevant scientific disciplines, prior experience in investment banking, management consulting, or direct industry experience within pharmaceutical or biotech companies. Such a background equips Associates like Jennie with the critical analytical skills and industry understanding necessary to navigate complex scientific and business challenges inherent in life sciences investing.
Bain Capital Life Sciences is committed to fostering innovation and bringing new therapies and technologies to patients worldwide. Jennie Daisak's involvement is integral to this commitment, as she helps to identify the next generation of healthcare leaders. Although specific notable investments attributed directly to Jennie are not typically highlighted at the Associate level, her contributions are vital to the collective success of the firm's investment strategies, which have historically included significant investments in companies developing novel treatments for various diseases, advanced medical technologies, and innovative healthcare solutions. Her work supports the firm's overarching goal of generating strong returns while making a meaningful difference in global health.
Jennie Daisak is an Associate at Bain Capital Life Sciences, a leading investment firm focused on the healthcare and life sciences sectors. She plays a key role in evaluating and supporting investment opportunities.
As part of Bain Capital Life Sciences, Jennie Daisak focuses on investments in innovative companies across the biotechnology, pharmaceutical, medical device, diagnostics, and digital health sectors. Her work involves identifying firms with the potential to advance healthcare.
Jennie Daisak works as an Associate at Bain Capital Life Sciences. This firm is a dedicated investment arm of Bain Capital, specializing in the life sciences industry.
